Founded in 2018, Espial has begun to disrupt the United States hemp concentrate market with an elegantly simple cannabinoid extraction system. Our goal
| Website | http://espialbiotech.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 4730 S Fort Apache Rd, Ste 300, Las Vegas, Nevada 89126, US |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Novartis, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Moderna Therapeutics, Lilly India +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Espial Biotech employee's phone or email?
The Espial Biotech annual revenue was $1 million in 2026.
Espial Biotech is based in Las Vegas, Nevada.
The NAICS codes for Espial Biotech are [325, 32, 3254].
The SIC codes for Espial Biotech are [283, 28, 80].